Related Experiment Video
Updated: Jul 29, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Non-steroidal anti-inflammatory drug-associated nephrotoxicity in Bartter syndrome
A D Schachter1, G S Arbus, R J Alexander
1Department of Pediatrics, The Hospital for Sick Children and University of Toronto, Ontario, Canada.
Abstract:
We have followed four patients with Bartter syndrome for a mean of 25.4 years (range 21.5-28.8 years) after diagnosis. All patients received non-steroidal anti-inflammatory drugs (NSAID). In all patients, various degrees of renal dysfunction were noted to be temporally associated with NSAID therapy. In two patients, renal dysfunction resolved after discontinuing NSAID therapy, while maintaining other chronic medications such as potassium-sparing diuretics. Renal dysfunction persisted after NSAID withdrawal in two patients. We report these cases as a warning that NSAID should be considered an important cause of either reversible or irreversible renal dysfunction in Bartter syndrome.
Insights
Non-steroidal anti-inflammatory drugs (NSAID) can cause reversible or irreversible kidney problems in patients with Bartter syndrome. This study highlights the importance of considering NSAID use when evaluating renal dysfunction in these patients.
Area of Science:
- Nephrology
- Pharmacology
- Genetics
Background:
- Bartter syndrome is a rare genetic kidney disorder affecting salt reabsorption.
- Long-term management often involves addressing electrolyte imbalances and potential complications.
- Non-steroidal anti-inflammatory drugs (NSAID) are sometimes used, but their renal effects in this population are not fully understood.
Purpose of the Study:
- To investigate the impact of non-steroidal anti-inflammatory drugs (NSAID) on renal function in patients with Bartter syndrome.
- To determine if NSAID-induced renal dysfunction is reversible in Bartter syndrome patients.
Main Methods:
- Longitudinal follow-up of four patients diagnosed with Bartter syndrome.
- Monitoring of renal function in relation to non-steroidal anti-inflammatory drug (NSAID) therapy.
- Assessment of renal function changes after NSAID withdrawal.
Main Results:
- All four patients received non-steroidal anti-inflammatory drugs (NSAID).
- Temporal association observed between NSAID use and varying degrees of renal dysfunction.
- Two patients showed resolved renal dysfunction after NSAID discontinuation.
- Two patients experienced persistent renal dysfunction despite NSAID withdrawal.
Conclusions:
- Non-steroidal anti-inflammatory drugs (NSAID) represent a significant risk factor for renal dysfunction in Bartter syndrome.
- NSAID-induced renal impairment can be either reversible or irreversible in these patients.
- Clinicians should carefully consider NSAID use as a potential cause of renal dysfunction in Bartter syndrome.
More Related Videos
10:15Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
14:18Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro
Published on: October 13, 2023
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention